Stanford-StartX Fund-backed microbial diagnostics and wellness product developer UBiome has raised $83m in series C funding.

UBiome, a US-based microbial genomics technology developer backed by the Stanford-StartX Fund, has raised $83m in series C funding from investors including Dentsu Ventures, the corporate venturing vehicle formed by marketing firm Dentsu.
The round was led by venture capital fund OS Fund and included 8VC, Y Combinator and undisclosed new and existing investors. It increased the company’s funding to $105m altogether.
Founded in 2012, UBiome is developing wellness products and diagnostics tests focusing on diseases such as…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?